SCHEMBL31744664

SCHEMBL31744664

Cn1cc(Oc2ccc(Br)cc2)c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.45
▸ GPR84 Q9NQS5 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ GSK3B P49841 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ IMPDH2 P12268 2/20 0.40
▸ NR4A2 P43354 1/20 0.40
▸ RHEB Q15382 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ NQO2 P16083 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PRKCA P17252 2/20 0.37
▸ BCHE P06276 1/20 0.37
▸ ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31744794 0.75 PRKCA (0.49) KMT2AGSK3BALDH1A1KDM4EMAPT
SCHEMBL12614276 0.73 GPR84 (0.52) KMT2AGPR84GSK3BALDH1A1IMPDH2
SCHEMBL31744863 0.72 KDM4E (0.55) KMT2AKDM4EMEN1PKM
SCHEMBL28241926 0.71 IMPDH2 (0.57) KMT2AGPR84GSK3BALDH1A1IMPDH2
SCHEMBL1606642 0.70 GPR84 (0.48) KMT2AGPR84ALDH1A1IMPDH2NR4A2
SCHEMBL3839100 0.70 ALDH1A1 (0.58) KMT2ASLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL31744892 0.69 LTA4H (0.39) KMT2ASLC6A2SLC6A4SLC6A3GSK3B
SCHEMBL1891947 0.69 GPR84 (0.55) KMT2AGPR84ALDH1A1IMPDH2NR4A2
SCHEMBL3867842 0.68 ALDH1A1 (0.47) KMT2AGPR84ALDH1A1IMPDH2NR4A2
SCHEMBL3971661 0.68 ALDH1A1 (0.56) KMT2AGPR84ALDH1A1IMPDH2NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 — — US claimed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 — — US disclosed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 KMT2A 4633/4885GPR84 4183/4885SLC6A2 2810/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 KMT2A 4633/4885GPR84 4183/4885SLC6A2 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback